SARS-CoV-2 Ikizamini cya Antigen (Zahabu ya Colloidal) -nasopharyngeal (NP) swab, izuru (NS) swab
Ibisobanuro:
Method Uburyo bwa zahabu
◮ Biroroshye gukora:izuru ryizuru, nasofaryngeal swabs hamwe namacandwe y'amacandwe birashobora gupimwa
Soma vuba ibisubizo:soma ibisubizo muminota 15
◮Ibyiyumvo bigera kuri 96.15% kandi umwihariko ugera kuri 99.1%
Ikizamini cya SARS-CoV-2 Antigen igamije kumenya neza antigen nucleacapsid proteine antigen ikomoka kuri SARS-CoV-2 muri nasopharyngeal (NP) na nasab (NS) swab, hamwe n'amacandwe y'amacandwe aturuka kubantu ku giti cyabo kandi ni ubufasha mu gusuzuma byihuse abarwayi bakekwaho kwandura SARS-CoV-2.
Ibisobanuro
1T / Kit, 20T / Kit
Ibiranga ibyiza
■Witonze witonze antibody idasanzwe ya monoclonal kuri nucleocapsid protein antigen yo muri SARS-CoV-2;
Ingero zitandukanye zikoreshwa;Nasopharyngeal (NP) swab, Nasal (NS) swab na Amacandwe;
Run Kwiruka byoroshye, byoroshye gusobanurwa n'amaso yambaye ubusa;
Result Ibisubizo by'ibizamini bizaboneka mu minota 15.
Imikorere
-GUKURIKIRA: 1.5 × 102TClD50kuri virusi lysate, 10pg / mL ya recombinant Nucleocapsid protein antigen.
-Gereranije nuburyo bwa NAT, ingero hamwe na Ct intera iri hagati ya 30-35 izamenyekana.
-Nta reaction zifatika hamwe na bagiteri zitandukanye, virusi nibihumyo mubisanzwe biboneka mumyanya y'ubuhumekero.
-Amasezerano meza (95% Cl): 30/31 96.8% (83.3% -99.9%)
-Amasezerano gakondo (95% Cl): 80/80 100.0% (95.5% -100%).
Ububiko
1. Igikoresho cyo kwipimisha cyumva ubushuhe kimwe nubushyuhe.
2. Bika ibikoresho bigize ibikoresho kuri 2-30 ° C, biturutse ku zuba ryinshi.Ibigize ibikoresho birahagaze kugeza igihe cyo kurangiriraho cyacapwe kumasanduku yo hanze.
3. Nyuma yo gufungura umufuka wa aluminiyumu, cassette yikizamini igomba gukoreshwa vuba bishoboka mumasaha abiri.
4. Ntukonje.
